Kai Zhang

4PUBLICATIONS
15CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 29, 2024
Which Is More Suitable for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer, PD-L1 Inhibitors Versus PD-1 Inhibitors? A Systematic Review and Network Meta-Analysis.

Wenjing Liu, Lulin Yu, Yuqian Feng

|Jan 22, 2024
Prognostic value of preoperative circulating tumor DNA in non-small cell lung cancer: a systematic review and meta-analysis.

Jiamin Lu, Yuqian Feng, Kaibo Guo

|Dec 08, 2023
Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: A systematic review and meta-analysis.

Xin Gao, Ying Zhu, Peipei Wang

|Oct 26, 2018
Jiedu Sangen Decoction Inhibits Migration and Invasion of Colon Cancer SW480 Cells via Suppressing Epithelial Mesenchymal Transition.

Kai Zhang, Tao Peng, Qingying Yan

Pageof 1

Frequent Collaborators

4 joint publications

Shanming Ruan

2 joint publications

Leitao Sun

1 joint publications

Tao Peng

1 joint publications

Qingying Yan